🇺🇸 Actrapid (human insulin) in United States

57 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Drug Interaction — 10 reports (17.54%)
  2. Hypoglycaemia — 8 reports (14.04%)
  3. Blood Creatinine Increased — 6 reports (10.53%)
  4. Bradycardia — 6 reports (10.53%)
  5. Coma — 6 reports (10.53%)
  6. Condition Aggravated — 5 reports (8.77%)
  7. Atrial Fibrillation — 4 reports (7.02%)
  8. Blood Glucose Increased — 4 reports (7.02%)
  9. C-Reactive Protein Increased — 4 reports (7.02%)
  10. General Physical Health Deterioration — 4 reports (7.02%)

Source database →

Other Diabetes approved in United States

Frequently asked questions

Is Actrapid (human insulin) approved in United States?

Actrapid (human insulin) does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Actrapid (human insulin) in United States?

University of Aarhus is the originator. The local marketing authorisation holder may differ — check the official source linked above.